15 February 2021 Priya Vaidya 1625 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) byPriya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles Draft report retains litigation privilege (at least for now) Access to Public Domain Documents Pilot will launch on the 1st January 2026 An unsatisfactory forensic medical report Sir Michael Davies Lecture 2025: Lady Simler, Enhancing Expert Evidence: Reports, Opinions, and Judicial Perspectives. Impact speed and risk of injury Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.